Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vext Science Inc C.VEXT

Alternate Symbol(s):  VEXTF

Healthcare Cannabis
Vext Science, Inc. is a cannabis operator. The Company’s expertise spans from cultivation through to retail operations in markets of Arizona and Ohio. It manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD and Herbal Wellness brands. It has THC concentrates, edibles, and... see more

CSE:VEXT - Post Discussion

Vext Science Inc > Vext Science Posts US$9.2 Million In Revenue For Q1 2021, Ne
View:
Post by AwareInvestor on May 26, 2021 8:23am

Vext Science Posts US$9.2 Million In Revenue For Q1 2021, Ne

Vext Science, Inc. released today its first quarter 2021 financial results, which saw the company post US$9.2 million in revenue. This is an increase from Q4 2020’s revenue of US$6.4 million and from Q1 2020’s revenue of US$4.1 million.
Be the first to comment on this post
Vext Science Inc